Ketesse

Dexketoprofen, the active ingredient in Ketesse, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an injectable solution for intramuscular or intravenous use. It is employed to treat acute pain, post‑operative discomfort, and musculoskeletal pain in adult patients requiring rapid analgesia.

GNH USA supplies Ketesse as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution, including emerging markets.

Dexketoprofen is indicated for the management of acute pain and inflammatory conditions.

Acute pain: provides rapid analgesia for severe short‑term pain episodes. Post‑operative pain: reduces discomfort following surgical procedures. Musculoskeletal pain: alleviates pain associated with injuries or inflammation of muscles and joints. Dental pain: offers effective relief after dental extractions or procedures.

Adverse reactions may occur with any NSAID therapy.

Common Side Effects: - Gastro‑intestinal discomfort such as nausea, dyspepsia or abdominal pain. - Headache or dizziness. - Injection site reactions including erythema or mild swelling. - Transient increase in blood pressure. - Mild renal function changes in susceptible individuals.

Serious or Rare Side Effects: - Gastro‑intestinal bleeding, ulceration or perforation. - Severe hypersensitivity reactions, including anaphylaxis or Stevens‑Johnson syndrome. - Cardiovascular events such as myocardial infarction or stroke. - Acute renal failure or significant decline in renal function. - Hepatic injury presenting with jaundice or elevated liver enzymes.

Careful assessment and monitoring are required when using injectable NSAIDs.

Assess renal function: evaluate baseline creatinine and adjust use in renal impairment. Monitor gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. Evaluate cardiovascular history: use cautiously in those with coronary artery disease or hypertension. Use caution in asthma: NSAIDs may trigger bronchospasm in susceptible individuals. Avoid in known hypersensitivity: discontinue immediately if allergic reactions occur. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Dexketoprofen may alter the activity of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened hemorrhagic potential. - ACE inhibitors or ARBs: possible reduction in renal perfusion. - Lithium: risk of lithium toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely): - Diuretics: may diminish antihypertensive effect. - Methotrexate: reduced clearance leading to toxicity. - Corticosteroids: synergistic risk of GI ulceration. - Cyclosporine: increased nephrotoxicity. - Antihypertensive agents: monitor blood pressure for additive effects.